Hinchcliff EM, Knisely A, Adjei N, Fellman B, et al. Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer. Cancer 2023 Nov 27. doi: 10.1002/cncr.35126.
PMID: 38009662